Assessment of microvascular changes by capillaroscopy in patients with foot mycoses and recurrent lower extremity erysipelas

DOI: https://doi.org/10.29296/25877305-2019-07-13
Download full text PDF
Issue: 
7
Year: 
2019

Professor O. Nemchaninova, MD; M. Shishkina; Professor O. Pozdnyakova, MD; Professor S. Lykova, MD Novosibirsk State Medical University

The mortality rates were estimated in patients with mycosis and recurrent erysipelas of the lower extremities. Capillaroscopy was used for the first time, which could identify predominantly spastic-atonic microcirculatory disorders in 83.9% of these patients. The efficiency of therapy was also evaluated. It was concluded that combination treatment for foot mycosis, by applying magnetic therapy, could reduce the mean diameters of the venous portion of the microvasculature by 1.5 times, bring the mean diameters of its arterial and transitional portions to the normal limits, and also increase the rates of clinical cure by 14.3% and mycological cure by 17.8% compared with those of standard therapy. The findings may suggest that it is feasible to use capillaroscopy in patients with foot mycoses associated with recurrent lower extremity erysipelas for identification of the type of microcirculation, which is important for the choice of therapy, as well as to evaluate the efficiency of magnetic therapy in these patients
Keywords: 
dermatology
foot mycosis
onychomycosis
recurrent lower extremity erysipelas
capillaroscopy
magnetic therapy

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Belousova T.A., Gorjachkina M.V. Sovremennyj vzgljad na problemu onihomikoza // Farmateka. – 2010; 11 (205): 32–7 [Belousova T.A., Gorjachkina M.V. Sovremennyj vzgljad na problemu onihomikoza // Farmateka. – 2010; 11 (205): 32–7 (in Russ.)].
  2. Vasil'eva N.V., Raznatovskij K.I., Kotrehova L.P. i dr. Monitorirovanie chuvstvitel'nosti klinicheski znachimyh mikromitsetov k izokonazolu, otsenka ego effektivnosti i bezopasnosti v terapii bol'nyh mikozami kozhi // Problemy meditsinskoj mikologii. – 2007; 9 (2): 19–22 [Vasilyeva N.V., Raznatovskij K.I., Kotrekhova L.P. et al. The monitoring of clinically important micromycetes to isoconazole and estimation of its efficiency and safety in treatment of patient swith skin mycoses // Problemy meditsinskoi mikologii. – 2007; 9 (2): 19–22 (in Russ.)].
  3. Kornisheva V.G., Pak E.Ju. Gipotsinkemija u bol'nyh mikozom stop i retsidivirujuschim rozhistym vospaleniem nizhnih konechnostej // Problemy meditsinskoj mikologii. – 2011; 4: 22–5 [Kornisheva V.G., Pak E.U. Hypozincemia in patients with tinea pedis and recurrent erysipelas of lower extremities // Problemy meditsinskoi mikologii. – 2011; 4: 22–5 (in Russ.)].
  4. Ratnikova L.I., Ship S.A., Bespalova M.K. i dr. Rozha, kak variant neinvazivnoj streptokokkovoj infektsii i komorbidnye kozhnye bolezni // Universum: meditsina i farmakologija. – 2016; 6: 28 [Ratnikova L., Ship S., Bespalova M. et al. Erysipelas as variant of noninvasive streptococcal infections, skin disease comorbidity // Universum: meditsina i farmakologiya. – 2016; 6: 28 (in Russ.)].
  5. Sergeev Ju.V., Sergeev A.Ju. Proekt «Gorjachaja linija»: itogi i rezul'taty // Uspehi meditsinskoj mikologii. – 2003; 2: 153–4 [Sergeev Yu.V., Sergeev A.Yu. Proekt «Goryachaya liniya»: itogi i rezul’taty // Uspekhi meditsinskoi mikologii. – 2003; 2: 153–4 (in Russ.)].
  6. Sergeev A.Ju. Gribkovye zabolevanija nogtej, 2-e izd. / M.: Natsional'naja akademija mikologii, 2007; s. 164 [Sergeev A.Yu. Gribkovye zabolevaniya nogtei, 2-e izd. / M.: Natsional’naya akademiya mikologii, 2007; s. 164 (in Russ.)].
  7. Ship S.A., Ratnikova L.I. Rozha kak raznovidnost' streptokokkovoj infektsii i problema komorbidnyh sostojanij // Vestnik soveta molodyh uchenyh i spetsialistov Cheljabinskoj oblasti. – 2016; 2 (3): 73–8 [Ship S.A., RATNIKOVA L.I. Erysipelas as a variety of streptococcal infection and the problem of comorbid conditions // Vestnik soveta molodykh uchenykh i spetsialistov Chelyabinskoi oblasti. – 2016; 2 (3): 73–8 (in Russ.)].
  8. Kushwaha A., Murthy R., Murthy S. et al. Emerging therapies for the treatment of ungual onychomycosis // Drug Dev. Ind. Pharm. – 2015; 41 (10): 1575–81.
  9. Onalan O., Adar A., Keles H. et al. Onychomycosis is associated with subclinical atherosclerosis in patients with diabetes // Vasa. – 2015; 44 (1): 59–64.
  10. Yannis Scrivener J. Onychomycoses //RFL – Revue francophone des laboratories. – 2011; 41 (432): 43–50.